Sahar Roshan

Sahar Roshan has extensive experience in the clinical operations field. Sahar currently holds the position of Director Clinical Operations at Mirati Therapeutics, a Bristol Myers Squibb Company, starting in 2024. Prior to that, they were also Director Clinical Operations at Mirati Therapeutics from 2020 to 2021, where they also served as Director Clinical Science from 2020 to 2021. Before joining Mirati Therapeutics, Sahar worked at Crinetics Pharmaceuticals as an Associate Director of Clinical Operations from 2019 to 2020. Sahar also held the role of Associate Director of Clinical Operations at Intercept Pharmaceuticals from 2018 to 2019 and at aTyr Pharma from 2015 to 2017. Prior to that, Sahar worked at The Medicines Company (formerly Rempex/Mpex Pharmaceuticals) as a Senior Clinical Project Manager from 2008 to 2015 and at Amylin Pharmaceuticals as a CTM from 2002 to 2008.

Sahar Roshan has a Bachelor of Science (BS) degree in Psychology/Biology from Boston University. They also obtained a Master of Business Administration (MBA) degree from the University of Phoenix. Additionally, Sahar has obtained a certification in "Confronting Bias: Thriving Across Our Differences" from LinkedIn in 2023.